Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · Real-Time Price · USD

0.2116

-0.0123 (-5.49%)

At close: Apr 1, 2025, 4:00 PM

0.2241

+0.0125 (5.89%)

After-hours: Apr 1, 2025, 4:29 PM EDT

Quoin Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Quoin Pharmaceuticals.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Quoin Pharmaceuticals.

Recommendation Trends

Rating	Oct '23	Nov '23	Dec '23	Jan '24	Feb '24
Strong Buy	3	3	3	3	3
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Naz Rahman Maxim Group	Maxim Group	Strong Buy Maintains $15 → $4	Strong Buy	Maintains	$15 → $4	+1,790.36%	Mar 15, 2024
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $240	Strong Buy	Initiates	$240	+113,321.55%	Sep 7, 2022
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+141,676.94%	May 6, 2022
Naz Rahman Maxim Group	Maxim Group	Strong Buy Initiates $750	Strong Buy	Initiates	$750	+354,342.34%	Jan 7, 2022
Jason Butler JMP Securities	JMP Securities	Buy Initiates $1,200	Buy	Initiates	$1,200	+567,007.75%	Dec 15, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 62.81M

Revenue Next Year

n/a

EPS This Year

-0.77

from -1.91

EPS Next Year

-0.41

from -0.77

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	14.68M	81.39M	49.98M	62.81M
Revenue Growth	-	-	454.38%	-38.60%	25.69%	-	-	-
EPS	-104.62	-815.39	-46.80	-9.64	-1.91	-0.77	-0.41	0.37
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	0.57
No. Analysts	-	-	-	-	-	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	16.5M	116.6M
Avg	n/a	14.7M	81.4M
Low	n/a	12.8M	47.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	694.4%
Avg	-	-	454.4%
Low	-	-	223.8%

EPS Forecast

EPS	2025	2026	2027
High	-0.46	-0.37	0.84
Avg	-0.77	-0.41	0.37
Low	-1.28	-0.44	-0.07

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.